Evidence map›Paper›PMID 42883827›Full record

ArticleInternational journal of molecular sciences2026

Janet Siles-Guevara, María Eva González-Trujano, Erika M Estrada-Camarena, Berenice Ovalle-Magallanes, Hermelinda Salgado-Ceballos, Lucía A Martínez-Mota, Myrna Déciga-Campos

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Janet Siles-GuevaraLaboratorio de Neurofarmacología de Productos Naturales, Dirección de Investigaciones Biomédicas en Salud Mental, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz. México-Xochimilco 101, Col. San Lorenzo Huipulco, Tlalpan, Ciudad de México 14370, Mexico.
María Eva González-TrujanoLaboratorio de Neurofarmacología de Productos Naturales, Dirección de Investigaciones Biomédicas en Salud Mental, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz. México-Xochimilco 101, Col. San Lorenzo Huipulco, Tlalpan, Ciudad de México 14370, Mexico.
Erika M Estrada-CamarenaLaboratorio de Neuropsicofarmacología, Dirección de Investigaciones Biomédicas en Salud Mental, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz. México-Xochimilco 101, Col. San Lorenzo Huipulco, Tlalpan, Ciudad de México 14370, Mexico.ORCID 0000-0001-6634-7494
Berenice Ovalle-MagallanesDepartamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.ORCID 0000-0002-4774-722X
Hermelinda Salgado-CeballosUnidad de Investigación Médica en Enfermedades Neurológicas, Hospital de Especialidades Dr. Bernardo Sepúlveda, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.ORCID 0000-0002-0715-9263
Lucía A Martínez-MotaSubdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz. México-Xochimilco 101, Col. San Lorenzo Huipulco, Tlalpan, Ciudad de México 14370, Mexico.
Myrna Déciga-CamposSección de Estudios de Posgrado e Investigación de la Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Col. Casco de Santo Tomas, Alcaldía Miguel Hidalgo, Ciudad de México 11340, Mexico.ORCID 0000-0002-1467-9486

Funding

Secretaría de Ciencia, Humanidades, Tecnología e Innovación 256448 (M.E.G.-T)/923250(J.S.-G.)
6 · The paper itself

Abstract

Fibromyalgia (FM) is a chronic, widespread musculoskeletal pain syndrome of still unknown etiology, characterized by allodynia and hyperalgesia. It affects between 2% and 8% of the population and is significantly more prevalent in women than in men. It is attributed to physiological, endocrine, immunological, and neurobiological variations that influence both pain development and the response to pharmacological treatments. Limited efficacy and a high incidence of adverse effects of current pharmacological treatments for FM have increased interest in the use of alternative therapies with medicinal plants. Non-polar extracts such as the essential oil of

Indexed as

AnalgesicsFibromyalgiaPainPlant ExtractsRosmarinusAnimalsDisease Models, AnimalFemaleHyperalgesiaMaleNociplastic PainRatsRats, WistarSex FactorsAnalgesicsPlant Extractsallodyniafibromyalgiahyperalgesiamedicinal plantsnociplastic painSalvia rosmarinussex

Identifiers

PMID42883827
PMCPMC13664948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.